Pseudotumor cerebri other diagnostic studies

Revision as of 14:50, 29 November 2018 by Fahimeh Shojaei (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Pseudotumor cerebri Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating pseudotumor cerebri from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pseudotumor cerebri other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudotumor cerebri other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pseudotumor cerebri other diagnostic studies

CDC on Pseudotumor cerebri other diagnostic studies

Pseudotumor cerebri other diagnostic studies in the news

Blogs on Pseudotumor cerebri other diagnostic studies

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Pseudotumor cerebri other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Other Diagnostic Studies

Other diagnostic studies for pseudotumor cerebri include:

  • Ophthalmologic evaluation:

Visual field testing includes goldmann kinetic perimetry and computer-assisted static perimetry.

The findings of perimetry in IIH patients are partial arcuate defect with enlargement of blind spot, generalized constriction and scotomas.[1][2][3][4]

opening pressure > 250 mmH2o (in normal obese individuals we may have CSF opening pressure as high as 250 mmH2o)

the content of CSF (cells, glucose and protein) is normal in IIH patients.[5]

References

  1. Wall M, George D (February 1991). "Idiopathic intracranial hypertension. A prospective study of 50 patients". Brain. 114 ( Pt 1A): 155–80. PMID 1998880.
  2. Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP (June 2014). "The idiopathic intracranial hypertension treatment trial: clinical profile at baseline". JAMA Neurol. 71 (6): 693–701. doi:10.1001/jamaneurol.2014.133. PMC 4351808. PMID 24756302.
  3. Acheson JF (2006). "Idiopathic intracranial hypertension and visual function". Br. Med. Bull. 79-80: 233–44. doi:10.1093/bmb/ldl019. PMID 17242038.
  4. Friedman DI (March 2001). "Papilledema and pseudotumor cerebri". Ophthalmol Clin North Am. 14 (1): 129–47, ix. PMID 11370563.
  5. Clinical Neurology 9E Aminoff

Template:WH Template:WS